ClinConnect ClinConnect Logo
Search / Trial NCT04485897

Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring

Launched by LUZERNER KANTONSSPITAL · Jul 21, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Glaucoma Self Monitoring Intraocular Pressure Icare Home Rebound Tonometry

ClinConnect Summary

This clinical trial is exploring whether patients with glaucoma can effectively monitor their own eye pressure at home, instead of relying solely on hospital visits. Glaucoma is a serious eye condition that can lead to vision loss, and high eye pressure is a major risk factor for it. The study aims to see if measuring eye pressure at different times throughout the day (known as diurnal monitoring) can help catch any spikes in pressure that might go unnoticed during regular hospital visits.

To participate in this trial, you need to be at least 18 years old and either have glaucoma or be a healthy control. You'll need to be able to follow the study's procedures and have a certain level of vision. If you join, you'll learn how to use a device to check your eye pressure at home, which could provide important information for managing your condition. The trial is currently looking for participants, and it’s a great opportunity to contribute to research that could improve care for glaucoma patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Informed consent
  • Subjects aged 18 and older
  • Glaucoma patients and healthy controls
  • Best corrected visual acuity \>0.1
  • Astigmatism ≤ 3dpt.
  • Good compliance
  • Central corneal thickness (400-650μm)
  • Passed certification procedure (detailed description under: Measurements and procedures)
  • Therapeutic regimen unchanged throughout the past 30 days
  • Exclusion Criteria:
  • History of ocular trauma
  • Corneal condition interfering with tonometry (keratoconus, corneal scaring) Visual acuity \<0.1
  • Physical or mental disability interfering with self-tonometry (e.g. arthritis, Parkinson's disease)
  • Dry eye disease
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Pregnancy
  • Breastfeeding

About Luzerner Kantonsspital

Luzerner Kantonsspital (LUKS) is a leading academic hospital located in Lucerne, Switzerland, dedicated to providing high-quality healthcare and advancing medical research. As a prominent clinical trial sponsor, LUKS is committed to fostering innovation in medical treatments and therapies through rigorous clinical studies. The institution emphasizes collaboration with multidisciplinary teams of healthcare professionals, researchers, and academic partners to ensure that its trials adhere to the highest ethical standards and regulatory requirements. With a focus on improving patient outcomes, LUKS leverages its state-of-the-art facilities and expertise to contribute significantly to the advancement of medical science.

Locations

Lucerne, , Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials